Today is HIV Vaccine Awareness Day, and we at VIRxSYS would like to recognize the thousands of volunteers, community leaders, health professionals, and scientists that work to develop a safe and effective preventive HIV vaccine. Existing HIV drugs are limited to merely treating symptoms and are facing serious obstacles to availability, even in wealthy nations. VIRxSYS is honored to be a part of the movement toward a solution to global HIV prevention and treatment with our research on vaccine therapies. A wealth of data from our research is being presented at the 13th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting this week, illustrating the potential of RNA therapies in developing a HIV vaccine as well as answers to other medical issues. HIV Vaccine Awareness Day calls attention to the need for an effective method of HIV prevention—VIRxSYS is committed to this goal and is optimistic that our research will contribute to a victory in the fight against global HIV/AIDS.